Your browser doesn't support javascript.
loading
Translational analysis and final efficacy of the AVETUX trial - Avelumab, cetuximab and FOLFOX in metastatic colorectal cancer.
Tintelnot, Joseph; Ristow, Inka; Sauer, Markus; Simnica, Donjete; Schultheiß, Christoph; Scholz, Rebekka; Goekkurt, Eray; von Wenserski, Lisa; Willscher, Edith; Paschold, Lisa; Lorenzen, Sylvie; Riera-Knorrenschild, Jorge; Depenbusch, Reinhard; Ettrich, Thomas J; Dörfel, Steffen; Al-Batran, Salah-Eddin; Karthaus, Meinolf; Pelzer, Uwe; Hinke, Axel; Bauer, Marcus; Massa, Chiara; Seliger, Barbara; Wickenhauser, Claudia; Bokemeyer, Carsten; Hegewisch-Becker, Susanna; Binder, Mascha; Stein, Alexander.
Afiliación
  • Tintelnot J; Department of Oncology and Hematology, Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Ristow I; Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Sauer M; Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Simnica D; Department of Internal Medicine IV - Oncology/Hematology, Martin-Luther-Universitat Halle-Wittenberg, Halle, Sachsen-Anhalt, Germany.
  • Schultheiß C; Department of Internal Medicine IV - Oncology/Hematology, Martin-Luther-Universitat Halle-Wittenberg, Halle, Sachsen-Anhalt, Germany.
  • Scholz R; Department of Internal Medicine IV - Oncology/Hematology, Martin-Luther-Universitat Halle-Wittenberg, Halle, Sachsen-Anhalt, Germany.
  • Goekkurt E; Department of Oncology and Hematology, Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • von Wenserski L; Hämatologisch-Onkologische Praxis Eppendorf, Hamburg, Germany.
  • Willscher E; Department of Internal Medicine IV - Oncology/Hematology, Martin-Luther-Universitat Halle-Wittenberg, Halle, Sachsen-Anhalt, Germany.
  • Paschold L; Department of Internal Medicine IV - Oncology/Hematology, Martin-Luther-Universitat Halle-Wittenberg, Halle, Sachsen-Anhalt, Germany.
  • Lorenzen S; Department of Internal Medicine IV - Oncology/Hematology, Martin-Luther-Universitat Halle-Wittenberg, Halle, Sachsen-Anhalt, Germany.
  • Riera-Knorrenschild J; Department of Internal Medicine III (Haematology/Medical Oncology), Technical University of Munich Hospital Rechts der Isar, Munchen, Bayern, Germany.
  • Depenbusch R; University Hospital of Giessen and Marburg, Marburg, Hessen, Germany.
  • Ettrich TJ; Private Practice Onkodoc GmbH Götersloh, Götersloh, Nordrhein-Westfalen, Germany.
  • Dörfel S; Department of Internal Medicine I, University Hospital Ulm, Ulm, Baden-Wörttemberg, Germany.
  • Al-Batran SE; Private Practice Onkozentrum Dresden, Dresden, Sachsen, Germany.
  • Karthaus M; Institute of Clinical Cancer Research Institut für Klinisch-Onkologische Forschung (IKF) at Northwest Hospital, Frankfurt, Hessen, Germany.
  • Pelzer U; Department of Hematology and Oncology, Munich Hospital Neuperlach, Munchen, Bayern, Germany.
  • Hinke A; Department of Hematology, Oncology and Tumorimmunology, Charite Universitatsmedizin Berlin, Berlin, Germany.
  • Bauer M; Clinical Cancer Research Consulting (CCRC), Dösseldorf, Germany.
  • Massa C; Institute of Pathology, Martin Luther University Halle Wittenberg, Halle, Sachsen-Anhalt, Germany.
  • Seliger B; Institute of Medical Immunology, Martin-Luther-Universität Halle-Wittenberg, Halle, Germany.
  • Wickenhauser C; Institute of Medical Immunology, Martin-Luther-Universität Halle-Wittenberg, Halle, Germany.
  • Bokemeyer C; Institute of Pathology, University Hospital Halle, Halle, Germany.
  • Hegewisch-Becker S; Department of Oncology and Hematology, Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Binder M; Hämatologisch-Onkologische Praxis Eppendorf, Hamburg, Germany.
  • Stein A; Department of Internal Medicine IV - Oncology/Hematology, Martin-Luther-Universitat Halle-Wittenberg, Halle, Sachsen-Anhalt, Germany.
Front Oncol ; 12: 993611, 2022.
Article en En | MEDLINE | ID: mdl-36605436
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Alemania